Status:
UNKNOWN
Cytometric Immunodiagnostics of Latent Tuberculosis Infection (LTBI)
Lead Sponsor:
Thomayer University Hospital
Collaborating Sponsors:
Charles University, Czech Republic
Conditions:
LTBI
BCG Vaccination Reaction
Eligibility:
All Genders
4-70 years
Brief Summary
TB-reactive immune cells will be tested in a multiparametric flow cytometry to distinguish an immune response for antigens of Mycobacterium spp. in TB disease/latent infection or a reaction after BCG ...
Detailed Description
The goal of this project is the verification of current cytometric panel of detection antibodies in a wider panel of stimulative immunodominant antigens for CD4+ and CD8+ T cells in combination with a...
Eligibility Criteria
Inclusion
- active TB, contact with TB infection in previous 3 months before the study
- \-
Exclusion
- HIV positive patients
Key Trial Info
Start Date :
January 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 26 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04673227
Start Date
January 2 2020
End Date
December 26 2022
Last Update
December 17 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Science
Prague, Czechia, 12800
2
Thomayer Hospital
Prague, Czechia, 14059